11/1/1999
FOR IMMEDIATE RELEASE
November, 1999
Enhanced NAMSA Surgical Capabilities
The surgical facilities at the Ohio division were recently remodeled and expanded to cover a wider range of procedures. Countless capabilities are available within the following areas: implantation (muscle, cheek pouch, brain, IOL, vascular, stent, shunt); anti-adhesion and wound healing studies; bone implant and joint procedures; tissue and vascular grafts; urethral sphincter augmentation and prostate procedures. A full array of laboratory animals are available for services offered. Three full-time staff DVMs provide their combined expertise in designing and performing surgical studies. Contact NAMSA technical staff for complete details.
NAMSA is a multinational company specializing in non-clinical testing to determine the safety and effectiveness of medical devices. Locations worldwide offer materials characterization, biocompatibility and microbial testing services. Products include: RSI® Rapid Indicators for monitoring steam sterilization processes, SPORTROL® biological sterilization indicators, chemical sterilization process indicators and H-BAC thromboresistant coating.
If you have any questions about the content of this press release, contact:
Mary Cox
NAMSA
419-666-9455, Ext. 422
FAX 419-666-2954
